In several horses referred for evaluation of colic, we observed marked leuk
openia (attributable to neutrophil counts <2,000/mu l) which was inconsiste
nt with the mild nature of abdominal pain, absence of fever, or lack of sig
ns of endotoxemia, In all cases, large bowel impaction had been diagnosed v
ia rectal palpation prior to admission and dioctyl sodium sulfosuccinate (D
SS) had been one of the medications administered. To investigate the hypoth
esis that DSS administration may lead to bowel irritation, margination of n
eutrophils, and development of leukopenia (neutropenia), the effects of DSS
administration (20 mg/kg via a nasogastric tube) on clinical and hematolog
ic values were studied in eight clinically normal horses. No changes were d
etected in any of the clinical values assessed in these horses and neither
leukopenia nor neutropenia was observed following DSS administration. A tre
nd for plasma total protein concentration to increase four hours after DSS
administration (in comparison to control data) suggested that DSS may enhan
ce secretion of fluid into the bowel in treated horses. In conclusion, the
results did not support the hypothesis that the leukopenia observed in hors
es with colic could be attributed to DSS administration. Whether DSS has mo
re significant effects in horses with altered bowel motility and mucosal in
tegrity during colic episodes is not known.